Work

Abstract B012: Effects of adagrasib on oncogenic signaling, immune cell regulation and biomarkers of response in preliminary clinical analyses

Year: 2023

Type: conference-abstract

Source: Molecular Cancer Research

DOI: 10.1158/1557-3125.ras23-b012

Authors: Jill Hallin, Laura Hover, Julio Fernandez-Benet, Adam Pavlicek, Kenna Anderes, Pasi A. Jänne, Gregory J. Riely, Alexander I. Spira, Jun Zhang, Peter Olson, James G. Christensen

Institutions: Mirati Therapeutics (United States), Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Virginia Cancer Specialists, University of Kansas Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367603405

Cites:

Cited by:

Related to: 10